-
Covaxin stock in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, Sisodia said
-
Imposing lockdown in a phased manner, Assam has tightened movement restrictions in urban and semi-urban areas.
-
The second wave will not come down in as steady a fashion as it did after the first wave.
-
The active cases have reduced to 37,04,099 comprising 15.87 % of the total infections, while the national COVID-19 recovery rate has improved to 83.04 %.
-
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur
-
As many as 125 centres administering Covaxin to 18-44 age group are likely to be closed down by Wednesday as the Delhi government did not receive new stock of the vaccine till Tuesday evening
-
Piyush Goyal, Additional Secretary, Union Home Ministry, also told a press conference that 5,805 MT of liquid medical oxygen is being imported from abroad considering the future needs of the country
-
At least 6,082 patients were discharged from hospitals during the day, taking the total of recoveries to 6,23,080
-
The states include Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh and West Bengal, Bharat Biotech said
-
The state has identified 2.04 crore people in the 18- 45 age group for whom the Covid-19 vaccine has to be administered